Profil
Campbell Wilson is currently a Director at Pharmaceutical Licensing Group Ltd. and a Director at Tarsis Technology Ltd. He previously worked as a Director-Executive Business Development at AstraZeneca PLC and as an Independent Non-Executive Director at Frontier IP Group Plc from 2014 to 2023.
Aktive Positionen von Campbell Wilson
| Unternehmen | Position | Beginn |
|---|---|---|
Pharmaceutical Licensing Group Ltd. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Campbell Wilson
| Unternehmen | Position | Ende |
|---|---|---|
| FRONTIER IP GROUP PLC | Direktor/Vorstandsmitglied | 21.04.2023 |
Tarsis Technology Ltd.
Tarsis Technology Ltd. Packaged SoftwareTechnology Services Develops and commercializes technology that allows delivery of drugs using metal-organic frameworks | Direktor/Vorstandsmitglied | 13.09.2022 |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Frontier IP Group Plc
Frontier IP Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the commercialization of intellectual property | Commercial Services |
Pharmaceutical Licensing Group Ltd. | |
Tarsis Technology Ltd.
Tarsis Technology Ltd. Packaged SoftwareTechnology Services Develops and commercializes technology that allows delivery of drugs using metal-organic frameworks | Technology Services |
















